Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

ABILIUM 15 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/ABILIUM 15 MG CAPSULAS DURAS EFG

Approved

STANDARD

ABILIUM 15 MG CAPSULAS DURAS EFG

Pharma2pharma Sp. Z O.O.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Jun 14, 2023
Approval ID: a8961f24683ce41f
Company: Pharma2pharma Sp. Z O.O.
Type: Standard

Approval Details

Approval Id: a8961f24683ce41f
Drug Cima Aemps Name: ABILIUM 15 MG CAPSULAS DURAS EFG
Register Number: 88907
Holder Company Name: Pharma2pharma Sp. Z O.O.
Marketing Company Name: Desitin Arzneimittel Gmbh
Marketing Company Detail Path: /organization/desitin-arzneimittel-gmbh
Authorization Date: 2023-06-14
Dosage Form: CÁPSULA DURA
Dose: 15 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: Yes
Company Name: Pharma2pharma Sp. Z O.O.

Company Information

Pharmaceutical Company Name: Desitin Arzneimittel Gmbh
Country Name: Norway
City Name: oslo,oslo,country_no
Address: c/o EconPartner AS Dronning Mauds gate 15
Website: http://www.desitin.de

Active Ingredients

ARIPIPRAZOL

15 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jun 14, 2023

Approval ID

a8961f24683ce41f

Type

Standard

Back to CIMA-AEMPS Approvals